Advancing Technology for Better Lives

Mission

We develop innovative solutions for better life. Our mission is to restore natural vessel function by replacing permanent metallic stents with safe, high-performance biodegradable solutions.

Vision

A future where every patient benefits from temporary scaffolding that supports vessel healing without leaving a permanent foreign object behind.  It redefines cardiovascular care with biodegradable stents – engineered to support, heal, and disappear.

Company Overview

We are a California-based medtech start-up dedicated to advancing cardiovascular care through the development of innovative biodegradable stents.  We are driving the innovation by advancing next-generation vascular technologies from early conceptual design through rigorous development and testing, ultimately bringing transformative solutions safely and efficiently to clinical practice to improve patient outcomes.

Our Technology

Cardiovascular disease remains the leading cause of death worldwide, with millions of patients undergoing stent implantation each year to restore blood flow in blocked arteries. While current permanent metal stents have saved countless lives, they leave a rigid, foreign scaffold inside the vessel for life — a factor linked to late complications such as thrombosis, inflammation, and impaired natural vessel motion.

A biodegradable stent, also known as bioresorbable vascular scaffold (BVS), is designed to solve this problem. It provides the strength and precision needed to reopen and support the artery during the critical healing phase, then gradually degrades for the surrounding tissues to absorb. The artery regains its normal flexibility and function, free from a permanent implant.  The biodegradable stent offers distinct advantages over permanent stents by supporting temporary scaffolding for vessel healing, restoring vessel natural vasomotion, leaving nothing behind, to reduce long-term risks such as late stent thrombosis.

We have developed an innovative metallic composite engineered to achieve superior mechanical strength for a thin strut and a degradation profile synchronized with vascular healing.  In-vivo studies on the proprietary biodegradable metallic stent demonstrated long-term patency, loss of mechanical integrity after healing, rapid re-endothelialization on struts, inhibition of neointimal hyperplasia, and minimal inflammatory response as assessed by histopathology.  This unique combination of biological performance and superior mechanical strength represents a significant advancement in BVS technology for the treatment of diseased arteries.